French news

Review of health news: Sanofi ordered to compensate a French family for the side effects of drugs against epilepsy; Britain delays ban on promotion of foods high in sugar and more

Here is a summary of health news briefs.

Sanofi ordered to compensate a French family for the side effects of a drug against epilepsy

A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by its epilepsy drug Valproate, saying the drug manufacturer had not informed of known side effects. The link, along with the physical deformity, was also acknowledged in a landmark class action ruling in January, which could potentially lead to hundreds of millions of euros in compensation, although Sanofi said it would file a lawsuit. .

Britain delays ban on promotion of foods high in sugar

Britain will delay new rules banning multiple buy offers on foods and drinks high in fat, salt or sugar (HFSS) for a year, as the government said on Saturday it needed more long given the cost of living crisis. The ban on offers, including “buy one, get one free” (BOGOF), “3 for 2” and restrictions on free soft drink refills, were due to come into effect in October.

Two further cases of monkeypox infection reported in England

Two more cases of the rare viral monkeypox infection have been diagnosed in England, health authorities said on Saturday, adding they were unrelated to the one reported a week ago. The UK Health Security Agency (UKHSA) said the latest infections involved people living in the same household and an investigation was underway into how they contracted the virus.

Shanghai aims to defeat COVID next week as Beijing retreats

Shanghai’s lockdown aims to contain its COVID outbreak over the next week, officials said on Friday, while residents of Beijing, the Chinese capital, have largely heeded authorities’ advice to work from home to stem the spread. spread of the virus. Easing weeks of punitive restrictions in the mall would bring relief to China’s struggling economy, although there are growing concerns that Beijing could yet take a similar course of action if it fails to control a nascent epidemic.

US FDA approves Eli Lilly treatment for type 2 diabetes

The U.S. Food & Drug Administration said on Friday it had approved tirzepatide, an injected drug from Eli Lilly, which goes by the brand name Mounjaro, to help improve blood sugar control in adults with type 2 diabetes. The FDA said Mounjaro, when taken with diet and exercise, improved blood sugar and was more effective than other diabetes therapies it has been compared with in clinical studies.

Biden says baby formula shortage will ease in weeks as US imports more

The shortage of infant formula in the United States is expected to improve significantly in the coming weeks, President Joe Biden and senior officials said Friday as the administration works to reverse a deficit that is hitting children especially hard. low-income Americans. The United States is working with manufacturers to allow more infant formula imports, Biden told reporters at the Rose Garden. “We’re going to, in a few weeks or less, be getting a lot more formula on the shelves,” he said.

Pfizer and EU delay delivery of COVID vaccine to help recall campaign

Pfizer Inc and its German partner BioNTech SE said on Friday they had agreed to push back deliveries of their COVID-19 vaccines to the European Union by three months as the bloc prepares for a possible recall campaign in the fall. . The companies amended their supply agreement with the European Commission to push back the delivery of doses planned for June-August through September to the fourth quarter of this year.

Abbott claims to have shipped millions of boxes of formula from Ireland

Abbott Laboratories said on Friday it had flown millions of boxes of infant formula powder to the United States from its factory in Ireland to address shortages here as it tries to reopen its Michigan manufacturing plant. The company said in a blog post that it ships infant formula produced in son Cootehill, Ireland This facility will be used by consumers eligible for the US government’s Women’s, Infants, and Children’s Nutrition Assistance (WIC) program for low-income families.

Blood marker identified for babies at risk of SIDS hailed as ‘breakthrough’

A team of Australian researchers have identified a biochemical marker in the blood that could help identify newborns at risk of sudden infant death syndrome (SIDS), a breakthrough they say paves the way for future health interventions. prevention of tragedies. In their study, babies who died of SIDS had lower levels of an enzyme called butyrylcholinesterase (BChE) shortly after birth, the researchers said. BChE plays a major role in the brain’s wakefulness pathway, and low levels are thought to reduce a sleeping infant’s ability to wake up or respond to their environment.

North Korea reports more deaths, says taking ‘swift action’ against COVID outbreak

North Korea said on Sunday a total of 42 people had died as the country entered its fourth day under a nationwide lockdown aimed at stopping the first confirmed outbreak of COVID-19 in the impoverished country. North Korea’s admission on Thursday that it is battling an ‘explosive’ COVID-19 outbreak has raised fears the virus could devastate a country with an underfunded health system, limited testing capacity and no programs vaccination.

(With agency contributions.)